期刊文献+

雷帕霉素对人胶质母细胞瘤细胞增殖及凋亡的影响

Effect of Rapamycin on Proliferation and Apoptosis in Human Glioblastoma Cell
下载PDF
导出
摘要 目的:探讨雷帕霉素对人胶质母细胞瘤细胞增殖及凋亡的影响。方法:细胞培养技术培养人胶质母细胞瘤细胞系A172,将其分为对照组与实验组。MTT检测两组细胞增殖;细胞免疫化学检测磷酸化核糖体S6激酶(p-P70S6K)1蛋白表达;TUNEL检测A172凋亡。结果:MTT表明,实验组细胞存活增殖与对照组比差异有统计学意义(P<0.05);实验组p-P70S6K1与对照组比差异有统计学意义(P<0.05);雷帕霉素可诱导A172凋亡(P<0.05)。结论:雷帕霉素能有效抑制人胶质母细胞瘤A172增殖,也可诱导其凋亡。雷帕霉素可能通过m TOR/P70S6K1信号通路发挥抗肿瘤作用。 Objective:To investigate the effect of rapamycin on the proliferation and apoptosis in human glioblastoma cell. Methods:The human glioblastoma cell line(A172)was cultivated with cell culture technology. The A172 cells were randomly divided into control and experimental groups. The MTT assay was used to detect the A172 proliferation between two groups. The immunocytochemistry was employed to evaluate the expression of phospho-p70S6 kinase(p-P70S6K)1 protein in A172. The cell apoptosis was tested by TUNEL. Results:The proliferation of A172 was significantly different between two groups by MTT assay(P0.05). There was statistical significance in p-P70S6K1 between two groups(P0.05). Rapamycin could induce the apoptosis of A172(P0.05). Conclusion:Rapamycin can significantly inhibit the proliferation of A172 and induce the apoptosis in vitro,and play a role of anti-tumor via downregulating the activity of m TOR/P70S6 K signaling pathway.
出处 《汕头大学医学院学报》 2015年第2期65-67,F0002,共4页 Journal of Shantou University Medical College
关键词 胶质母细胞瘤 雷帕霉素 磷酸化核糖体S6激酶1 glioblastoma rapamycin phospho-p70S6 kinase1
  • 相关文献

参考文献6

  • 1JI-IPNWAR U M, GILLICK J L, NElL J, et al. Distinct signaling mecfianisms of mTORC1 and mTORC2 in gliorolastoma multiforme: a tale of two complexes[J]. Adv BiolRegul, 2015, 57: 64-74. 被引量:1
  • 2关良,冯健男,王国华,阙海萍,刘少君.人突变型TRAIL体外诱导脑恶性胶质瘤细胞凋亡的研究[J].中华神经外科杂志,2004,20(4):315-318. 被引量:6
  • 3DANCEY J E. Clinical development of mammalian target of rapamycin inhibitors [J]. Hematol Oncol Clin North Am, 2002, 6(5): 1101-1114. 被引量:1
  • 4XU G, ZHANG W, BERTRAM P, et al. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors[J]. Int J Oncol, 2004, 24(4): 893-900. 被引量:1
  • 5AOKI M, BLAZEK E, VOGT PK. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt [J]. Proc Natl Acad Sci U S A, 2001, 98 (1) : 136-141. 被引量:1
  • 6CIUFFREDA L, DI SANZA C, INCANI U C, et al. The mTOR pathway: A new target in cancer therapy[J]. Curr Cancer Drug Targets, 2010, 10(5) : 484-495. 被引量:1

二级参考文献10

  • 1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induced apoptosis. Immunity, 1995, 3: 673-682. 被引量:2
  • 2Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med,1999, 5: 157-163. 被引量:2
  • 3Nagane M, Pan G, Weddle JJ, et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-induing ligand in vitro and in vivo. Cancer Res, 2000, 60: 84 被引量:2
  • 4Frank S, Kohler U, Schackert G, et al. Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun,1999, 257: 454-459. 被引量:2
  • 5Pan G, O-Rourke K, Chinaiyan AM, et al. The receptor for cytotoxic ligand TRAIL. Science, 1997, 276: 111-113. 被引量:2
  • 6Schneider P, Thome M, Burns K, et al. TRAIL receptors 1 (DR4)and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity, 1997, 7: 831-836. 被引量:2
  • 7Kischkel FC, Lawrence DA, Chuntharapai A, et al. Apo21/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 2000, 12: 611-620. 被引量:2
  • 8Knight MJ, Riffrin CD, Muscat AM. Analzsis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene, 2001, 20:5789-5798. 被引量:2
  • 9Arizono Y, Yoshikawa H, Naganuma H, et al. A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitization to TRAIL by genotoxic agents. Br J of cancer, 2003, 88 (2): 298-306. 被引量:1
  • 10pan G, Ni Jian, Wei Ying-fei, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science, 1997, 277: 815-818. 被引量:2

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部